Literature DB >> 20095037

Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family study.

Christine E McLaren1, James C Barton, John H Eckfeldt, Gordon D McLaren, Ronald T Acton, Paul C Adams, Leora F Henkin, Victor R Gordeuk, Chris D Vulpe, Emily L Harris, Barbara W Harrison, Jacob A Reiss, Beverly M Snively.   

Abstract

Heritability is the proportion of observed variation in a trait among individuals in a population that is attributable to hereditary factors. The Hemochromatosis and Iron Overload Screening family study estimated heritability of serum iron measures. Probands were HFE C282Y homozygotes or non-C282Y homozygotes with elevated transferrin saturation (TS > 50%, men; TS > 45%, women) and serum ferritin concentration (SF > 300 microg/L, men; SF > 200 microg/L, women). Heritability (h(2)) was estimated by variance component analysis of TS, natural logarithm (ln) of SF, and unsaturated iron-binding capacity (UIBC). Participants (N = 942) were 77% Caucasians, 10% Asians, 8% Hispanics, and 5% other race/ethnicities. Average age (SD) was 49 (16) years; 57% were female. For HFE C282Y homozygote probands and their family members, excluding variation due to HFE C282Y and H63D genotype and measured demographic and environmental factors, the residual h(2) (SE) was 0.21 (0.07) for TS, 0.37 (0.08) for ln SF, and 0.34 (0.08) for UIBC (all P < 0.0004 for comparisons with zero). For the non-C282Y homozygote proband group, residual h(2) was significant with a value of 0.64 (0.26) for ln SF (P = 0.0096). In conclusion, serum iron measures have significant heritability components, after excluding known genetic and nongenetic sources of variation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20095037      PMCID: PMC3816512          DOI: 10.1002/ajh.21585

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  37 in total

1.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

2.  Prevalence of hemochromatosis among 11,065 presumably healthy blood donors.

Authors:  C Q Edwards; L M Griffen; D Goldgar; C Drummond; M H Skolnick; J P Kushner
Journal:  N Engl J Med       Date:  1988-05-26       Impact factor: 91.245

Review 3.  Management of hemochromatosis. Hemochromatosis Management Working Group.

Authors:  J C Barton; S M McDonnell; P C Adams; P Brissot; L W Powell; C Q Edwards; J D Cook; K V Kowdley
Journal:  Ann Intern Med       Date:  1998-12-01       Impact factor: 25.391

4.  The significance of the 187G (H63D) mutation in hemochromatosis.

Authors:  E Beutler
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

5.  Haemochromatosis and HLA-H.

Authors:  A M Jouanolle; G Gandon; P Jézéquel; M Blayau; M L Campion; J Yaouanq; J Mosser; P Fergelot; B Chauvel; P Bouric; G Carn; N Andrieux; I Gicquel; J Y Le Gall; V David
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

6.  Multipoint quantitative-trait linkage analysis in general pedigrees.

Authors:  L Almasy; J Blangero
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

7.  The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding.

Authors:  J N Feder; D M Penny; A Irrinki; V K Lee; J A Lebrón; N Watson; Z Tsuchihashi; E Sigal; P J Bjorkman; R C Schatzman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

8.  Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults.

Authors:  Christine E McLaren; James C Barton; Paul C Adams; Emily L Harris; Ronald T Acton; Nancy Press; David M Reboussin; Gordon D McLaren; Phyliss Sholinsky; Ann P Walker; Victor R Gordeuk; Catherine Leiendecker-Foster; Fitzroy W Dawkins; John H Eckfeldt; Beverly G Mellen; Mark Speechley; Elizabeth Thomson
Journal:  Am J Med Sci       Date:  2003-02       Impact factor: 2.378

9.  Relative importance of female-specific and non-female-specific effects on variation in iron stores between women.

Authors:  John B Whitfield; Susan Treloar; Gu Zhu; Lawrie W Powell; Nicholas G Martin
Journal:  Br J Haematol       Date:  2003-03       Impact factor: 6.998

Review 10.  Hereditary hemochromatosis--a new look at an old disease.

Authors:  Antonello Pietrangelo
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

View more
  6 in total

1.  IRon Overload screeNing tool (IRON): development of a tool to guide screening in primary care.

Authors:  Arch G Mainous; Vanessa A Diaz; Charles J Everett; Michele E Knoll; Mary M Hulihan; Althea M Grant; Christine E McLaren; Gordon D McLaren
Journal:  Am J Hematol       Date:  2011-07-28       Impact factor: 10.047

2.  GNPAT p.D519G is independently associated with markedly increased iron stores in HFE p.C282Y homozygotes.

Authors:  James C Barton; Wen-Pin Chen; Mary J Emond; Pradyumna D Phatak; V Nathan Subramaniam; Paul C Adams; Lyle C Gurrin; Gregory J Anderson; Grant A Ramm; Lawrie W Powell; Katrina J Allen; John D Phillips; Charles J Parker; Gordon D McLaren; Christine E McLaren
Journal:  Blood Cells Mol Dis       Date:  2016-11-12       Impact factor: 3.039

3.  Genome-wide association study identifies genetic loci associated with iron deficiency.

Authors:  Christine E McLaren; Chad P Garner; Clare C Constantine; Stela McLachlan; Chris D Vulpe; Beverly M Snively; Victor R Gordeuk; Debbie A Nickerson; James D Cook; Catherine Leiendecker-Foster; Kenneth B Beckman; John H Eckfeldt; Lisa F Barcellos; Joseph A Murray; Paul C Adams; Ronald T Acton; Anthony A Killeen; Gordon D McLaren
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

4.  Associations between single nucleotide polymorphisms in iron-related genes and iron status in multiethnic populations.

Authors:  Christine E McLaren; Stela McLachlan; Chad P Garner; Chris D Vulpe; Victor R Gordeuk; John H Eckfeldt; Paul C Adams; Ronald T Acton; Joseph A Murray; Catherine Leiendecker-Foster; Beverly M Snively; Lisa F Barcellos; James D Cook; Gordon D McLaren
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

5.  An efficient machine learning-based approach for screening individuals at risk of hereditary haemochromatosis.

Authors:  Patricia Martins Conde; Thomas Sauter; Thanh-Phuong Nguyen
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

6.  Oxidative and glycolytic skeletal muscles deploy protective mechanisms to avoid atrophy under pathophysiological iron overload.

Authors:  David Martin; Kévin Nay; François Robin; Amélie Rebillard; Luz Orfila; Brice Martin; Patricia Leroyer; Pascal Guggenbuhl; Suzanne Dufresne; Philippe Noirez; Martine Ropert; Olivier Loréal; Frédéric Derbré
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-02-03       Impact factor: 12.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.